Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F <scp>e</scp> NO) for Clinical Applications

Raed A. Dweik, Peter B. Boggs, Serpil C. Erzurum et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 2.5K citations

Medicine, Clinical Sciences, Internal Medicine +8

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 2.1K citations

Public Health, Pharmacotherapy, Allergy +16

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

Prescott G. Woodruff, Barmak Modrek, David F. Choy et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 1.8K citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

Ruth H. Green, Christopher E. Brightling, Susan McKenna et al. · The Lancet · 2002 · 1.8K citations

Medicine, Immunology, Internal Medicine +14